Supervised Outdoor-Use Test For Sunscreen Products in Adults
NCT02877511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2018-12-13
Summary
To assess the safety of a sunscreen product under supervised outdoor-use conditions
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
BAY987517
Applied liberally to the skin (Formulation: Y73-161
- DRUG
-
Sunscreen Lotion (Y65-110)
Applied liberally to the skin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-08-20
- Primary Completion
- 2016-08-21
- Completion
- 2016-08-21
Countries
- United States
Study Locations
More Related Trials
-
Human Phototoxicity Test (823/2016)
NCT02962856 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
Kinetic Time Courses of Bisphenol-S in Volunteers
NCT03340168 ·Status: UNKNOWN ·Phase: NA
-
Validation of Drug Assays in Various Biological Matrices
NCT02283112 ·Status: RECRUITING
-
Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function
NCT05283915 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
NCT01336387 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers
NCT05830799 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
NCT03102489 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers
NCT02668367 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury
NCT06888115 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
NCT00583713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States
NCT01722669 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phototoxicity of Frequently Prescribed Medicines
NCT06710600 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
NCT03080298 ·Status: COMPLETED ·Phase: PHASE2
-
A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT
NCT04193436 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NST-6179 in Healthy Subjects
NCT05181085 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment
NCT02427035 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
NCT04332432 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
NCT01933503 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers
NCT02191852 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults
NCT01050127 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-279 in Adults With or Without Liver Damage
NCT05976321 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
NCT00359177 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012
NCT05017987 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects
NCT03235076 ·Status: COMPLETED ·Phase: PHASE1